Exagen, Inc. (XGN)
7.15
+0.13
(+1.85%)
USD |
NASDAQ |
Dec 10, 16:00
7.15
0.00 (0.00%)
After-Hours: 19:58
Exagen Market Cap: 162.04M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| FONAR Corp. | 93.19M |
| XWELL, Inc. | 4.482M |
| ProPhase Labs, Inc. | 6.608M |
| Veracyte, Inc. | 3.424B |
| Insight Molecular Diagnostics, Inc. | 150.49M |
Market Cap Related Metrics
| PS Ratio | 2.277 |
| Price to Book Value | 8.934 |
| Price | 7.15 |
| Earnings Yield | -12.95% |